Pathstone Holdings
PRAX icon

Pathstone Holdings’s Praxis Precision Medicines PRAX Stock Holding History

Pathstone Holdings’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$748K Buy
+2,567
New +$849K ﹤0.01% 1681

Other funds holding PRAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return

Pathstone Holdings's PRAX Position: Q3 2026 in Review

Pathstone Holdings opened a new position in Praxis Precision Medicines (PRAX) in Q3 2026: 2,567 shares worth $748K. The stake represents ﹤0.01% of the portfolio and ranks #1681 among its holdings.

237 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

  • Pathstone Holdings held 2,567 shares of Praxis Precision Medicines worth $748K as of Q3 2026.
  • Praxis Precision Medicines was a new Pathstone Holdings position in Q3 2026.
  • Praxis Precision Medicines made up ﹤0.01% of Pathstone Holdings's portfolio in Q3 2026, its #1681 holding.
  • 237 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on Pathstone Holdings's 13F filing for Q3 2026, filed 13 Nov 2026.